AMC
AMC Entertainment Holdings, Inc.
AMC has the edge over ANGI overall, supported by stronger fundamentals and stronger modeled upside.
ANGI
Angi Inc.
ANGI has slightly lower modeled downside risk, despite its lower overall score.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
ANGI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Under pressure |
ANGI's revenue, profitability, cash flow and balance sheet are all currently under pressure.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
ANGI PE Valuation
ANGI has no meaningful PE right now: it lost money over the past year.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AMC has the edge over ANGI on the outlook, with more favorable revenue expectations.
ANGI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Decline | |
| Improving | |
| Limited | |
| Low |
Analysts expect ANGI's earnings to grow and its profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC has the edge over ANGI on earnings, with more consistent year-over-year improvement.
ANGI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.41 | — |
| Q3 2026 | -$5.71 | -965% |
| Q2 2026 | -$5.51 | -588% |
| Q1 2026 | $0.42 | -58% |
| Q4 2025 | $0.94 | +34% |
| Q3 2025 | $0.66 | -5.7% |
| Q2 2025 | $1.13 | +$1.23 |
| Q1 2025 | $1.00 | +$1.50 |
| Q4 2024 | $0.70 | +$1.50 |
ANGI has swung to a loss: it lost $5.71 per share over the past year, after a profit the year before.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC has the edge over ANGI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC has the edge over ANGI on profitability, with a higher operating margin.
ANGI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $242M | -8.9% |
| Q2 2026 | $248M | -11% |
| Q1 2026 | $238.2M | -3.2% |
| Q4 2025 | $240.8M | -10% |
| Q3 2025 | $265.6M | -10% |
| Q2 2025 | $278.2M | -12% |
| Q1 2025 | $245.9M | -19% |
| Q4 2024 | $267.9M | +22% |
ANGI's revenue has slid since its 2022 peak: $242M last quarter, down 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.4% | -1.8 points |
| Q2 2026 | -94% | -101 points |
| Q1 2026 | -4% | -12 points |
| Q4 2025 | 2.5% | +1.7 points |
| Q3 2025 | 8.2% | +5.6 points |
| Q2 2025 | 6.3% | +3.4 points |
| Q1 2025 | 8.1% | +7.2 points |
| Q4 2024 | 0.8% | -4.1 points |
ANGI's operating margin was 6.4% last quarter, down 1.8 points from the same quarter a year ago.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over ANGI on cash flow, with more consistent year-over-year improvement.
ANGI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.4M | +192% |
| Q2 2026 | $12.2M | -73% |
| Q1 2026 | -$33.6M | -$17.9M |
| Q4 2025 | $11.4M | -58% |
| Q3 2025 | $4.9M | -74% |
| Q2 2025 | $44.9M | -10% |
| Q1 2025 | -$15.7M | -265% |
| Q4 2024 | $27.1M | +$33.4M |
ANGI still generates free cash flow, though less than at its 2020 peak: $4M over the past year.
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
ANGI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 0.7x | Very low |
| Q3 2024 | 0.9x | Very low |
| Q2 2024 | 1.0x | Healthy |
ANGI's net debt is about 2.6 years of its operating earnings (EBITDA), up from a year a year ago.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
ANGI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 69.1 | Neutral |
ANGI's weekly RSI is 50 (neutral) and its Stochastic is 69 (neutral).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
ANGI PE vs Communication Services Sector
| Metric | ANGI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
ANGI has no meaningful PE right now: it lost money over the past year.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over ANGI on trend strength, trading above more of its moving averages.
ANGI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.26 | 1.1% above |
| 20 week MA | $5.71 | 11% above |
| 50 week MA | $7.58 | 16% below |
| 100 week MA | $11.6 | 45% below |
| 200 week MA | $18.0 | 65% below |
ANGI has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 65% below its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over ANGI on returns for 2026, with the stronger performance.
ANGI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $83.6 | $132.7 | +59% |
| 2021 | $132.7 | $94.3 | -29% |
| 2022 | $94.3 | $22.3 | -76% |
| 2023 | $22.3 | $24.9 | +12% |
| 2024 | $24.9 | $16.5 | -34% |
| 2025 | $16.5 | $12.7 | -23% |
| 2026 YTD | $12.7 | $6.33 | -50% |
ANGI has finished lower in four of the last six years. It's down 50% so far in 2026.